Amplification of CD274 has been observed in the setting of EBV-positive gastric cancer (Cancer Genome Atlas Research Network 2014) and in samples of Hodgkin’s lymphoma from patients who have had a clinical response to PD-1 inhibition (Ansell et al. 2015). This evidence concerns the gene CD274 and Hodgkins lymphoma.